Prelude Therapeutics director David P. Bonita acquires $12.5 million in stock



[
Prelude Therapeutics director David P. Bonita acquires $12.5 million in stock
[og_img]
https://www.investing.com/news/insider-trading-news/prelude-therapeutics-director-david-p-bonita-acquires-125-million-in-stock-93CH-4634467


Investing.com

Latest articles

spot_imgspot_img

Related articles

Leave a reply

Please enter your comment!
Please enter your name here

spot_imgspot_img